CYP2D6代谢器表型对EDDP/甲代谢比率的影响:综合分析
Verena Wilmes1, Mattias Kettner1, Eva Corvest1
1Institute of Legal Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Forensic science international
|March 13, 2025
概括
在CYP2D6影响甲代谢的遗传变异,导致中介代谢剂中较高的EDDP/甲比率. 这一发现对于理解甲毒性和死后病例的法医分析至关重要.
科学领域:
- 药物遗传学 药物遗传学
- 法医毒理学 法医毒理学
- 临床化学 临床化学
背景情况:
- 甲是一种合成阿片类药物,用于治疗疼痛和预防戒断.
- 高度的甲可以引起严重的副作用,如呼吸抑制.
- 细胞染色体P450 (CYP) 酶,特别是CYP2D6,CYP2C19和CYP2B6,对于将甲转化为2-乙烯-1,5-二甲基-3,3二甲 (EDDP) 的代谢至关重要.
- 在CYP基因中的遗传变异 (多态) 可以改变甲代谢,影响药物水平和EDDP/甲代谢比率,用于法医毒理学.
研究的目的:
- 调查CYP2D6,CYP2C19和CYP2B6代谢器表型与死后血液样本中的甲中毒类型,度和代谢比率之间的关联.
- 为了确定遗传变异是否影响已故甲使用者的EDDP/甲代谢比率.
主要方法:
- 分析了来自甲使用者的37个死后血液样本.
- 确定EDDP/甲代谢比率.
- 使用SNaPshot分析对CYP2D6,CYP2C19和CYP2B6进行基因定型.
- 对CYP2D6的定量PCR (qPCR) 拷贝数变异分析.
- 基于DPWG和CPIC指南的代谢器表型的确定.
主要成果:
- 与正常代谢剂 (NM) 相比,在CYP2D6中间代谢剂 (IM) 中观察到明显增加的EDDP/甲代谢比率.
- 与NM,低代谢 (PM) 和超快代谢 (UM) 相比,CYP2D6 IM在混合中毒和非中毒的情况下表现出明显更高的代谢比率.
结论:
- CYP2D6代谢器状态,特别是中间代谢器表型,与改变的甲代谢比率 (EDDP/甲) 有关.
- 这些发现突显了药物遗传学对甲代谢的影响,以及其在死后法医调查中的比例.
- 了解这些遗传影响对于解释法医毒理学中甲度和代谢比率至关重要.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
67
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
67
Factors Affecting Drug Biotransformation: Biological
94
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
94
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
150
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
150
Nonlinear Pharmacokinetics: Role of Transporters
25
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
25
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Nonlinear Pharmacokinetics: Causes of Nonlinearity
105
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
105


